420 with CNW — Study Shows Marijuana Extracts Notably Improve Symptoms of Cancer Patients

A new clinical study indicates that cannabis-derived medicinal extracts may help reduce several symptoms associated with cancer, including difficulty sleeping and anxiety, though patient responses varied considerably depending on which cannabinoid profile worked best for each individual. 

The study team evaluated oil-based formulations with different proportions of cannabidiol (CBD) and tetrahydrocannabinol (THC) using a randomized, placebo-controlled trial that was triple-blinded to reduce bias. 

Overall results suggest that cannabis oil treatments produced meaningful relief in about half of participants, with improvements most often reported in sleep-related issues and closely connected symptoms. When outcomes were averaged across the study population, no single formulation consistently showed superior performance compared with the others. 

Among the 89 participants who had complete Patient Global Impression of Change records, 56% experienced at least a 1.4-point improvement relative to placebo when using one or more active extracts. In subgroup analyses, response rates were recorded at 50% for pain, 47% for sleep difficulties, and 60% for anxiety. Around two-thirds of participants said they preferred an active cannabinoid product over placebo. 

The study also found that a low-dose regimen combining 2.5 milligrams of THC and CBD taken three times per day was generally well tolerated. Even so, the researchers stressed that better outcomes are likely achieved when treatment is tailored rather than standardized across patients. 

According to the authors, a universal recommendation is unlikely to fit the wide range of biological differences seen in patients. Variations in the endocannabinoid system may help explain why some individuals respond better to certain extracts than others. 

The findings add to expanding scientific work exploring cannabis compounds in cancer care. Earlier reviews have suggested possible anti-tumor activity in specific cancers such as glioblastoma and breast tumors, along with evidence that cannabinoids may improve the effectiveness of chemotherapy. 

CBD has also been highlighted in multiple analyses for its potential anti-cancer properties, anti-inflammatory effects, and possible role in slowing tumor growth and spread across cancers including lung, colorectal, ovarian, and prostate. 

A 2025 study also examined existing clinical and laboratory data, suggesting cannabinoid use may enhance how standard chemotherapy drugs perform. 

Separately, earlier research has reported that many cancer patients who use cannabis describe noticeable improvements in symptom severity and overall quality of life. 

Researchers say further large-scale trials will be needed to determine optimal dosing strategies and long-term safety, particularly as interest in cannabinoid-based therapies continues to grow in oncology care settings worldwide. 

These scientific findings confirming that marijuana products indeed confer medical benefits upon cancer patients are likely to be welcomed by industry firms like Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) that sell medical marijuana products aimed at helping cancer patients manage their symptoms. 

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Archives

Select A Month
  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • September 2016
  • August 2016
  • July 2016
  • Official NewsWire Relationships

    Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

    CannabisNewsWire Currently Accepts

    Bitcoin

    Bitcoin

    Bitcoin Cash

    Bitcoin Cash

    Doge Coin

    Dogecoin

    Ethereum

    Ethereum

    Litecoin

    Litecoin

    USD Coin

    USD Coin

    Contact us: 512.354.7000